About this trial
The goal of this study is to establish the ICP and CPP monitoring process and analyze the results in post-arrest patients, to validate the correlation between direct and non-invasive ICP monitoring indicators, to establish a protocol of management of elevated ICP and insufficient CPP in post-arrest care, to establish a protocol for personalizing CPP and MAP optimization, and to analyze its impact on neuroprognosis.
Participants will receive ICP monitoring within 12 hours post-ROSC if meet all inclusion and exclusion criteria.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
non-traumatic cardiac arrest
admitted to ICU
GCS: motor <=5
severity: TIMECARD score medium-risk group
Disqualifiers
traumatic cardiac arrest
pregnancy
intracranial hemorrhage
coagulopathy
Trial design
Single group
Treatments tested in this trial
ICP monitoring
DeviceICP monitoring
Treatment groups
Trial outcomes
Primary outcomes
ICP difference between different temperature
Secondary outcomes
Difference between direct and non-invasive ICP monitoring indicators
Sponsors and contacts
Click on the lead sponsor to view all of their trials.